M&A - AVANOS MEDICAL, INC.

Form Type: 10-K

Filing Date: 2025-02-26

Corporate Action: Acquisition

Type: New

Accession Number: 000160649825000024

Filing Summary: Avanos Medical, Inc. released its annual 10-K report for the fiscal year ending December 31, 2024. The report outlines the company's focus on developing medical device solutions that improve patient outcomes. Major areas of operation include Digestive Health, highlighted by their MIC-KEY enteral feeding tubes and Corpak feeding solutions. The Pain Management segment consists of innovative non-opioid solutions such as surgical pain pumps and minimally invasive interventional pain therapies. Key highlights from the report include the completion of the acquisition of Dir, as well as insights into their market positioning and future strategies amidst economic uncertainties and competitive pressures. The document emphasizes challenges faced due to factors like supply chain disruptions, pricing pressures, and fluctuating economic conditions. Forward-looking statements regarding future performance and risks associated with their business model are also included, alongside financial disclosures and information about their operational facilities in the U.S. and Mexico. The company remains committed to enhancing healthcare solutions and minimizing opioid dependency in patient recovery. Notably, Avanos Medical’s common stock is listed on the New York Stock Exchange under the ticker AVNS.

Document Link: View Document